Find us on FaceBookFollow Us On Twitter
Home | Appointments | About The Center
Johns Hopkins Arthritis CenterJohns Hopkins Medicine
  • Arthritis Info
  • Patient Resources
  • Physician Resources
  • Arthritis News
  • Arthritis Research
  • Ask The Expert
  • Rheumatoid Arthritis
  • Treatment Strategies
  • TNF Antagonists
  • B-Cell Depletion
  • Other Agents
  • Safety
  • OA Clinical Aspects
  • Juvenile RA / Pediatric Rheumatology
  • Systemic Lupus Erythematosus
  • Vasculitis
  • Scleroderma
  • Fibromyalgia
  • Spondyloarthropathies
  • Myositis
  • Pregnancy in AutoImmune Disease
  • Non-Pharmacologic Management
  • Basic Science
  • Epidemiology
  • Psychosocial
ACR 2006 Highlights from Johns Hopkins University
Home > ACR 2006 Highlights > RA > Safety

Rheumatoid Arthritis Safety

Clifton Bingham, M.D.

L43. The Efficacy and Safety of Abatacept or Infliximab in RA Patients with an Inadequate response to MTX: Results from a 1-year Double-blind, Randomized, Placebo-controlled Trial

footer line

  • Rheumatoid Arthritis
  • Treatment Strategies
  • TNF Antagonists
  • B-Cell Depletion
  • Other Agents
  • OA Clinical Aspects
  • Juvenile RA / Pediatric Rheumatology
  • Systemic Lupus Erythematosus
  • Vasculitis
  • Scleroderma
  • Fibromyalgia
  • Spondyloarthropathies
  • Myositis
  • Pregnancy in AutoImmune Disease
  • Non-Pharmacologic Management
  • Basic Science
  • Epidemiology
  • Psychosocial

Signup For Our Email Newsletter

Sitemap | Copyright |Privacy Policy | RSS |Contact Us | Johns Hopkins Rheumatology